139 related articles for article (PubMed ID: 38331746)
21. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the clinical efficacy of vaginal treatment options for persistent high-risk human papillomavirus infection after excisional treatment of cervical high-grade squamous intraepithelial lesions: a systematic review and Bayesian network meta-analysis.
Tang Y; Tong Q; Dai N; Xu C
Virol J; 2023 Mar; 20(1):47. PubMed ID: 36935507
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of human papillomavirus infection by dry vaginal swabs in military women.
Shah KV; Daniel RW; Tennant MK; Shah N; McKee KT; Gaydos CA; Gaydos JC; Rompalo A
Sex Transm Infect; 2001 Aug; 77(4):260-4. PubMed ID: 11463925
[TBL] [Abstract][Full Text] [Related]
24. Association of abnormal vaginal microflora and HPV infection in cervical precancerous lesions: a retrospective study.
Yu H; Ma L; Bian M; Li Q; Liang H
J Infect Dev Ctries; 2022 Jun; 16(6):1089-1095. PubMed ID: 35797305
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
Belinson JL; Hu S; Niyazi M; Pretorius RG; Wang H; Wen C; Smith JS; Li J; Taddeo FJ; Burchette RJ; Qiao YL
Int J Cancer; 2010 Sep; 127(5):1151-7. PubMed ID: 20039323
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women.
Liu S; Mei B; Ouyang Y; Li C
Virol J; 2023 Dec; 20(1):297. PubMed ID: 38102627
[TBL] [Abstract][Full Text] [Related]
27. Surfactant Protein A Impairs Genital HPV16 Pseudovirus Infection by Innate Immune Cell Activation in A Murine Model.
Ujma S; Carse S; Chetty A; Horsnell W; Clark H; Madsen J; Mackay RM; Watson A; Griffiths M; Katz AA; Schäfer G
Pathogens; 2019 Dec; 8(4):. PubMed ID: 31817644
[No Abstract] [Full Text] [Related]
28. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
29. Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study.
Oakeshott P; Aghaizu A; Reid F; Howell-Jones R; Hay PE; Sadiq ST; Lacey CJ; Beddows S; Soldan K
BMJ; 2012 Jun; 344():e4168. PubMed ID: 22730542
[TBL] [Abstract][Full Text] [Related]
30. Association Between Common Vaginal Infections and Cervical Non-Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women.
Hu SY; Tsang SH; Chen F; Pan QJ; Zhang WH; Hong Y; Sampson JN; Hildesheim A; Zhao FH; Kreimer AR
J Infect Dis; 2021 Feb; 223(3):445-451. PubMed ID: 32614401
[TBL] [Abstract][Full Text] [Related]
31. [Prognosis of high-risk HPV infection and its influences by vaginal micro-environmental factors].
Meng D; Song L; Qi Z; Wang J; Liu H; Lyu YJ; Jia HX; Ding L; Hao M; Tian ZQ; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jun; 42(6):1103-1107. PubMed ID: 34814515
[No Abstract] [Full Text] [Related]
32. Microbiota unbalance in relation to high-risk human papillomavirus cervical infection.
Gomez Cherey JF; Payalef SN; Fleider L; Reyes AP; Maldonado VA; Losada MO; Chen X; Cardinal LH; Wang Y; Tatti SA; Perazzi BE
Int J Gynecol Cancer; 2023 Apr; 33(4):482-488. PubMed ID: 36604120
[TBL] [Abstract][Full Text] [Related]
33. Triage of Women Testing Positive With the careHPV Test on Self-Collected Vaginal Samples for Cervical Cancer Screening in a Low-Resource Setting.
Poli UR; Gowrishankar S; Swain M; Jeronimo J
J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241206
[TBL] [Abstract][Full Text] [Related]
34. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
35. Detection of Oncogenic Human Papillomavirus (HPV-16 and HPV-18) from Bacterial Vaginosis Positive Patient Attending at Tertiary Care Hospital in Mymensingh.
Paul A; Sarker S; Banik BC; Paul A; Paul SK; Nasreen SA; Haque N; Ahmed S; Khanam J; Arafa P; Nila SS; Chowdhury CS; Das AK; Das K
Mymensingh Med J; 2023 Oct; 32(4):959-967. PubMed ID: 37777887
[TBL] [Abstract][Full Text] [Related]
36. The Significance of Human Papillomavirus Receptors Related Genetic Variants in Cervical Cancer Screening.
Xie H; Wei M; Yao L; Liu Y; Xie X; Li X
Microbiol Spectr; 2023 Aug; 11(4):e0511722. PubMed ID: 37358427
[TBL] [Abstract][Full Text] [Related]
37. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of high-risk human papillomavirus infection rate and genotype distribution between Han and Mongolian women].
Zhao S; Zhao XL; Hu SY; Wang Y; Remila R; Xu XQ; Duan XZ; Chen F; Zhang X; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1439-1444. PubMed ID: 31838818
[No Abstract] [Full Text] [Related]
39. Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry.
Jailani AS; Balqis-Ali NZ; Tang KF; Fun WH; Samad SA; Jahaya R; Subakir NN; Ismail R; Said ZM; Sararaks S
BMC Public Health; 2023 Nov; 23(1):2243. PubMed ID: 37964260
[TBL] [Abstract][Full Text] [Related]
40. Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2.
Berggrund M; Gustavsson I; Aarnio R; Lindberg JH; Sanner K; Wikström I; Enroth S; Bunikis I; Olovsson M; Gyllensten U
Virol J; 2020 Oct; 17(1):147. PubMed ID: 33028395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
